Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.56
+0.06 (0.41%)
At close: Feb 26, 2026, 4:00 PM EST
14.64
+0.08 (0.55%)
After-hours: Feb 26, 2026, 7:53 PM EST
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $669.82 million as of February 26, 2026.
Market Cap
669.82M
Enterprise Value
708.04M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.56
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $669.82M, an increase of 104.92%. That is a compound annual growth rate of 138.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 667.06M | -6.03% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 692.78M |
| ProKidney | 649.80M |
| enGene Holdings | 647.74M |
| Lexicon Pharmaceuticals | 644.90M |
| Vor Biopharma | 640.24M |
| Alpha Tau Medical | 623.28M |
| Rigel Pharmaceuticals | 621.87M |
| LB Pharmaceuticals | 607.43M |